Magee-Women's Research Institute and Foundation donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

We do not have any donee information for the donee Magee-Women's Research Institute and Foundation in our system.

Donation amounts by donor and year for donee Magee-Women's Research Institute and Foundation

Donor Total 2016 2015 2014 2013 2012 2011 2009 2007
Bill and Melinda Gates Foundation (filter this donee) 15,631,721.00 -639,953.00 437,420.00 2,074,695.00 2,233,232.00 5,757,867.00 4,480,565.00 398,700.00 889,195.00
Total 15,631,721.00 -639,953.00 437,420.00 2,074,695.00 2,233,232.00 5,757,867.00 4,480,565.00 398,700.00 889,195.00

Full list of donations in reverse chronological order (12 donations)

DonorAmount (current USD)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation-639,953.002016-10-10Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of the ex vivo challenge assay to provide an optimized bio-indicator of product efficacy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation437,420.002015-07-23Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to identify changes in HIV-target cells occuring in the genital tract of women initiating hormonal contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,499,998.002014-11-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support research into products which provide both contraception and HIV prevention to women; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation574,697.002014-06-24Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to identify changes in HIV-target cells occuring in the genital tract of women initiating hormonal contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation-37,674.002014-04-30Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a specimen repository for HIV-related biomarker assessments in microbicide clinical trials of topical microbicides; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation37,674.002014-04-30Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of the ex vivo challenge assay to provide an optimized bio-indicator of product efficacy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,233,232.002013-11-07Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of the ex vivo challenge assay to provide an optimized bio-indicator of product efficacy; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation757,868.002012-10-08Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to landscape production and delivery options for dual protection vaginal films. Films as a Vaginal Drug Delivery Platform. Investment start date: 10/8/2012 to end date: 10/31/2014. Grantee name: Magee-Women's Research Institute and Foundation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,999,999.002012-09-20Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to identify changes in HIV-target cells occuring in the genital tract of women initiating hormonal contraception; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation4,480,565.002011-10-27Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to conduct a Phase 1 study that will inform the future development of an HIV prevention indication; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation398,700.002009-10-14Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- for conference support. Microbicides 2010 Conference. Investment start date: 10/14/2009 to end date: 5/31/2010. Grantee name: Magee-Women's Research Institute and Foundation; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation889,195.002007-10-08Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support a specimen repository for HIV-related biomarker assessments in microbicide clinical trials of topical microbicides; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.